Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that utilizes best-in-class, proprietary genome editing technologies to develop targeted, life-saving therapeutics in areas of high unmet medical need. We have demonstrated proof-of-principle that validates the potential of our differentiated genome engineering technologies and their therapeutic applications. Our technology platforms have broad applicability and Poseida’s long-term goal is to apply its proprietary gene editing technologies to a broad range of human diseases. The initial applications of Poseida’s technologies will be in gene therapy and CAR-T product candidates for liver disorders and cancer, respectively.
|
|
|
|
|
201-500 employees
View all Poseida Therapeutics employees
|
|
|
IT Services and IT Consulting
|
|
|
La Jolla, California
|
|
|
2015
|
The decision makers in Poseida Therapeutics are Angie Schinkel, Carol Susla, Debbie Gessner, etc. Click to Find Poseida Therapeutics decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.